Basic Information
| RNALocate ID: | RLID:11001882 |
| RNA Symbol: | hsa-miR-126-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-126-3p |
| RNA ID: | miRBase:MIMAT0000445 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25242326 |
| Tissue/Cell Line: | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells |
| Method: | Next-generation RNA sequencing |
| Description: | Although the miRNA distribution in exosomal fractions is clearly influenced by cellular miRNA abundance, we identified a subset of miRNAs that were discordantly distributed between cells and exosomes (false discovery rate [FDR] < 0.05; Tables S1B and S1C). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001817 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001818 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001819 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001875 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001876 | Exosome | Human umbilical vein endothelial cells|Serum | 29127370 |
| RLID:11001877 | Exosome | B cell line (Raji) | 21505438 |
| RLID:11001878 | Exosome | Breast milk | 22211110 |
| RLID:11001879 | Exosome | Brain tissue | 23382797 |
| RLID:11001880 | Exosome | Plasma | 23663360 |
| RLID:11001881 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001883 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001884 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001885 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000093 | Exosome | Blood|Endothelial cells|Epithelial cells|Mast cells | |
| RLID-D:11000373 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-126-3p | Diffuse large b cell lymphoma | MNDR-E-MI-07897 |
| MNDR | hsa-miR-126-3p | Splenic marginal zone lymphoma | MNDR-E-MI-07898 |
| MNDR | hsa-miR-126-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-07899 |
| MNDR | hsa-miR-126-3p | Oral squamous cell carcinoma | MNDR-E-MI-07900 |
| MNDR | hsa-miR-126-3p | Large cell neuroendocrine cancer | MNDR-E-MI-07901 |
| MNDR | hsa-miR-126-3p | Medulloblastoma | MNDR-E-MI-07902 |
| MNDR | hsa-miR-126-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-07903 |
| MNDR | hsa-miR-126-3p | Ovarian clear cell carcinoma | MNDR-E-MI-07904 |
| MNDR | hsa-miR-126-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07905 |
| MNDR | hsa-miR-126-3p | Lymphoma | MNDR-E-MI-07906 |
| MNDR | hsa-miR-126-3p | Lymphoma non-hodgkin | MNDR-E-MI-07907 |
| MNDR | hsa-miR-126-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07908 |
| MNDR | hsa-miR-126-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07909 |
| MNDR | hsa-miR-126-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07910 |
| MNDR | hsa-miR-126-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07911 |
| MNDR | hsa-miR-126-3p | Her2-receptor positive breast cancer | MNDR-E-MI-07912 |
| MNDR | hsa-miR-126-3p | Triple negative breast cancer | MNDR-E-MI-07913 |
| MNDR | hsa-miR-126-3p | Acute promyelocytic leukemia | MNDR-E-MI-07914 |
| MNDR | hsa-miR-126-3p | Breast cancer luminal | MNDR-E-MI-07915 |
| MNDR | hsa-miR-126-3p | Anencephaly | MNDR-E-MI-07916 |
| MNDR | hsa-miR-126-3p | Niemann-pick disease type c | MNDR-E-MI-07917 |
| MNDR | hsa-miR-126-3p | Congenital myopathy | MNDR-E-MI-07918 |
| MNDR | hsa-miR-126-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-07919 |
| MNDR | hsa-miR-126-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-07920 |
| MNDR | hsa-miR-126-3p | Dermatomyositis | MNDR-E-MI-07921 |
| MNDR | hsa-miR-126-3p | Prostate cancer | MNDR-E-MI-07922 |
| MNDR | hsa-miR-126-3p | Gastric cancer | MNDR-E-MI-07923 |
| MNDR | hsa-miR-126-3p | Gastric lymphoma | MNDR-E-MI-07924 |
| MNDR | hsa-miR-126-3p | Alzheimer disease | MNDR-E-MI-07925 |
| MNDR | hsa-miR-126-3p | Intracranial aneurysm | MNDR-E-MI-07926 |
| MNDR | hsa-miR-126-3p | Sarcoma | MNDR-E-MI-07927 |
| MNDR | hsa-miR-126-3p | Dysautonomia familial | MNDR-E-MI-07928 |
| MNDR | hsa-miR-126-3p | Head and neck cancer | MNDR-E-MI-07929 |
| MNDR | hsa-miR-126-3p | Leukemia | MNDR-E-MI-07930 |
| MNDR | hsa-miR-126-3p | Friedreich ataxia | MNDR-E-MI-07931 |
| MNDR | hsa-miR-126-3p | Huntington disease | MNDR-E-MI-07932 |
| MNDR | hsa-miR-126-3p | Chorea | MNDR-E-MI-07933 |
| MNDR | hsa-miR-126-3p | Cardiovascular disease | MNDR-E-MI-07934 |
| MNDR | hsa-miR-126-3p | Moyamoya disease | MNDR-E-MI-07935 |
| MNDR | hsa-miR-126-3p | Lung cancer | MNDR-E-MI-07936 |
| MNDR | hsa-miR-126-3p | Biliary atresia | MNDR-E-MI-07937 |
| MNDR | hsa-miR-126-3p | Down syndrome | MNDR-E-MI-07938 |
| MNDR | hsa-miR-126-3p | Parkinson disease | MNDR-E-MI-07939 |
| MNDR | hsa-miR-126-3p | Niemann-pick disease | MNDR-E-MI-07940 |
| MNDR | hsa-miR-126-3p | Primary pulmonary hypertension | MNDR-E-MI-07941 |
| MNDR | hsa-miR-126-3p | Breast cancer | MNDR-E-MI-07942 |
| MNDR | hsa-miR-126-3p | Squamous cell carcinoma | MNDR-E-MI-07943 |
| MNDR | hsa-miR-126-3p | Thyroid cancer | MNDR-E-MI-07944 |
| MNDR | hsa-miR-126-3p | Pituitary neoplasms | MNDR-E-MI-07945 |
| MNDR | hsa-miR-126-3p | Pancreatic cancer | MNDR-E-MI-07946 |
| MNDR | hsa-miR-126-3p | Hepatitis C | MNDR-E-MI-07947 |
| MNDR | hsa-miR-126-3p | Melanoma | MNDR-E-MI-07948 |
| MNDR | hsa-miR-126-3p | Rectum adenocarcinoma | MNDR-E-MI-07949 |
| MNDR | hsa-miR-126-3p | Nephroblastoma | MNDR-E-MI-07950 |
| MNDR | hsa-miR-126-3p | Colon cancer | MNDR-E-MI-07951 |
| MNDR | hsa-miR-126-3p | Colon adenocarcinoma | MNDR-E-MI-07952 |
| MNDR | hsa-miR-126-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07953 |
| MNDR | hsa-miR-126-3p | Familial ovarian cancer | MNDR-E-MI-07954 |
| MNDR | hsa-miR-126-3p | Acromegaly | MNDR-E-MI-07955 |
| MNDR | hsa-miR-126-3p | Prostate adenocarcinoma | MNDR-E-MI-07956 |
| MNDR | hsa-miR-126-3p | Kidney cancer | MNDR-E-MI-07957 |
| MNDR | hsa-miR-126-3p | Carcinoma ductal breast | MNDR-E-MI-07958 |
| MNDR | hsa-miR-126-3p | Invasive ductal carcinoma | MNDR-E-MI-07959 |
| MNDR | hsa-miR-126-3p | Glioblastoma | MNDR-E-MI-07960 |
| MNDR | hsa-miR-126-3p | Astrocytoma | MNDR-E-MI-07961 |
| MNDR | hsa-miR-126-3p | Glioma | MNDR-E-MI-07962 |
| MNDR | hsa-miR-126-3p | Oligodendroglioma | MNDR-E-MI-07963 |
| MNDR | hsa-miR-126-3p | Chordoma | MNDR-E-MI-07964 |
| MNDR | hsa-miR-126-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-07965 |
| MNDR | hsa-miR-126-3p | Osteosarcoma | MNDR-E-MI-07966 |
| MNDR | hsa-miR-126-3p | Liposarcoma | MNDR-E-MI-07967 |
| MNDR | hsa-miR-126-3p | Coronary artery disease | MNDR-E-MI-07968 |
| MNDR | hsa-miR-126-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07969 |
| MNDR | hsa-miR-126-3p | Liver cancer | MNDR-E-MI-07970 |
| MNDR | hsa-miR-126-3p | Pituitary adenoma | MNDR-E-MI-07971 |
| MNDR | hsa-miR-126-3p | Lung squamous cell carcinoma | MNDR-E-MI-07972 |
| MNDR | hsa-miR-126-3p | Carcinoma lung non-small-cell | MNDR-E-MI-07973 |
| MNDR | hsa-miR-126-3p | Lung adenocarcinoma | MNDR-E-MI-07974 |
| MNDR | hsa-miR-126-3p | Thyroid carcinoma | MNDR-E-MI-07975 |
| MNDR | hsa-miR-126-3p | Tuberculosis | MNDR-E-MI-07976 |
| MNDR | hsa-miR-126-3p | Ovarian carcinoma | MNDR-E-MI-07977 |
| MNDR | hsa-miR-126-3p | Bladder urothelial carcinoma | MNDR-E-MI-07978 |
| MNDR | hsa-miR-126-3p | Pancreatic adenocarcinoma | MNDR-E-MI-07979 |
| MNDR | hsa-miR-126-3p | Liver disease | MNDR-E-MI-07980 |
| MNDR | hsa-miR-126-3p | Carcinoma renal cell | MNDR-E-MI-07981 |
| MNDR | hsa-miR-126-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07982 |
| MNDR | hsa-miR-126-3p | Clear cell renal cell carcinoma | MNDR-E-MI-07983 |
| MNDR | hsa-miR-126-3p | Large cell carcinoma | MNDR-E-MI-07984 |
| MNDR | hsa-miR-126-3p | Biliary tract cancer | MNDR-E-MI-07985 |
| MNDR | hsa-miR-126-3p | Brain edema | MNDR-E-MI-07986 |
| MNDR | hsa-miR-126-3p | Cholangiocarcinoma | MNDR-E-MI-07987 |
| MNDR | hsa-miR-126-3p | Esophageal cancer | MNDR-E-MI-07988 |
| MNDR | hsa-miR-126-3p | Liver cirrhosis | MNDR-E-MI-07989 |
| MNDR | hsa-miR-126-3p | Small cell lung cancer | MNDR-E-MI-07990 |
| MNDR | hsa-miR-126-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-07991 |
| MNDR | hsa-miR-126-3p | Myocardial infarction | MNDR-E-MI-07992 |
| MNDR | hsa-miR-126-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-07993 |
| MNDR | hsa-miR-126-3p | Fibromyalgia | MNDR-E-MI-07994 |
| MNDR | hsa-miR-126-3p | Encephalomyelitis | MNDR-E-MI-07995 |
| MNDR | hsa-miR-126-3p | Pulmonary arterial hypertension | MNDR-E-MI-07996 |
| MNDR | hsa-miR-126-3p | Adenoma | MNDR-E-MI-07997 |
| MNDR | hsa-miR-126-3p | Breast invasive carcinoma | MNDR-E-MI-07998 |
| MNDR | hsa-miR-126-3p | Early hepatocellular carcinoma | MNDR-E-MI-07999 |
| MNDR | hsa-miR-126-3p | Familiar ovarian carcinoma | MNDR-E-MI-08000 |
| MNDR | hsa-miR-126-3p | B-cell lymphoma | MNDR-E-MI-08001 |
| MNDR | hsa-miR-126-3p | Rheumatoid arthritis | MNDR-E-MI-08002 |
| MNDR | hsa-miR-126-3p | T-cell leukemia | MNDR-E-MI-08003 |
| MNDR | hsa-miR-126-3p | Neuroblastoma | MNDR-E-MI-08004 |
| MNDR | hsa-miR-126-3p | Chronic kidney disease | MNDR-E-MI-08005 |
| MNDR | hsa-miR-126-3p | Chronic myeloid leukemia | MNDR-E-MI-08006 |
| MNDR | hsa-miR-126-3p | Hodgkin lymphoma | MNDR-E-MI-08007 |
| MNDR | hsa-miR-126-3p | Ulcerative colitis | MNDR-E-MI-08008 |
| MNDR | hsa-miR-126-3p | Burkitt lymphoma | MNDR-E-MI-08009 |
| MNDR | hsa-miR-126-3p | Tonsil cancer | MNDR-E-MI-08010 |
| MNDR | hsa-miR-126-3p | Neuromyelitis optica | MNDR-E-MI-08011 |
| MNDR | hsa-miR-126-3p | Acute myelocytic leukemia | MNDR-E-MI-08012 |
| MNDR | hsa-miR-126-3p | Colorectal cancer | MNDR-E-MI-08013 |
| MNDR | hsa-miR-126-3p | Nasopharynx carcinoma | MNDR-E-MI-08014 |
| MNDR | hsa-miR-126-3p | Diabetes mellitus | MNDR-E-MI-08015 |
| MNDR | hsa-miR-126-3p | Type 2 diabetes mellitus | MNDR-E-MI-08016 |
| MNDR | hsa-miR-126-3p | Multiple myeloma | MNDR-E-MI-08017 |
| MNDR | hsa-miR-126-3p | Ependymoma | MNDR-E-MI-08018 |
| MNDR | hsa-miR-126-3p | Nasopharyngeal cancer | MNDR-E-MI-08019 |
| MNDR | hsa-miR-126-3p | Prostatic neoplasms | MNDR-E-MI-08020 |
| MNDR | hsa-miR-126-3p | Sleep deprivation | MNDR-E-MI-08021 |
| MNDR | hsa-miR-126-3p | Aids dementia complex | MNDR-E-MI-08022 |
| MNDR | hsa-miR-126-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-08023 |
| MNDR | hsa-miR-126-3p | Gait ataxia | MNDR-E-MI-08024 |
| MNDR | hsa-miR-126-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-08025 |
| MNDR | hsa-miR-126-3p | Pancreatitis chronic | MNDR-E-MI-08026 |
| MNDR | hsa-miR-126-3p | Chronic pain | MNDR-E-MI-08027 |
| MNDR | hsa-miR-126-3p | Stroke lacunar | MNDR-E-MI-08028 |
| MNDR | hsa-miR-126-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-08029 |
| MNDR | hsa-miR-126-3p | Breast cancer her3+ negative | MNDR-E-MI-08030 |
| MNDR | hsa-miR-126-3p | High grade dysplastic nodule | MNDR-E-MI-08031 |
| MNDR | hsa-miR-126-3p | Tubulovillous adenoma | MNDR-E-MI-08032 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM9 | Homo sapiens | RR00041155 |
TOP